Evaluation of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit
Purpose
To compare the results obtained by analysis of a self-collected anterior nasal (AN) swab as part of the Labcorp COVID-19+Flu+RSV Test Home Collection Kit to a healthcare provider (HCP)-collected AN swab in patients with symptoms of viral respiratory infection consistent with influenza A (Flu A), influenza B (Flu B), respiratory syncytial virus (RSV) and/or SARS-CoV-2 (C-19).
Conditions
- COVID-19 Respiratory Infection
- Influenza A
- Influenza Type B
- RSV Infection
Eligibility
- Eligible Ages
- Between 2 Years and 89 Years
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- presents with symptoms of viral respiratory infection consistent with Flu A, Flu B, RSV and/or C-19; - Subject can read and understand written instructions in English; and - Subject is able, in the professional opinion of the investigator, to provide up to 18.5mL of whole blood at the clinic visit. NOTE - the blood draw will be optional for subjects <12 years of age.
Exclusion Criteria
- Subject is 14-17 years of age and their parent or legal guardian is unable to supervise the collection of the AN swab sample from the subject; - Subject is <14 years of age and their parent or legal guardian refuses to collect the AN swab sample from the subject; or - Previous participation in this protocol.
Study Design
- Phase
- Study Type
- Observational [Patient Registry]
- Observational Model
- Cohort
- Time Perspective
- Prospective
Arm Groups
Arm | Description | Assigned Intervention |
---|---|---|
Self-collection first | Subjects will self-collect an anterior nasal swab first |
|
HCP-collection first | Subjects will have their healthcare provider collect an anterior nasal swab first |
|
Recruiting Locations
More Details
- NCT ID
- NCT06008457
- Status
- Completed
- Sponsor
- Sequenom, Inc.